Company Profile

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.

Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

Our mission at CollPlant is to deliver ground-breaking products for regenerative medicine that offer the optimal treatment options to patients.

Latest Presentation

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

Contact Information

Investor Relations
Eran Rotem
Deputy CEO & CFO
T: +972 (73) 2325612
F: +972 (73) 2325602
eran@collplant.com

The Sophia Consulting Firm
Sophia Ononye-Onyia, PhD MPH MBA
(At Rockefeller Center)
1270 Ave of the Americas, 7th Fl -1026
New York, NY 10020
T: +1 347-851-8674
F: +1 347-851-1625

Company Contact
CollPlant Biotechnologies Ltd.
4 Oppenheimer St.,
P.O.B 4132
Rehovot 7670104,
Israel